Balaxi Pharmaceuticals Ltd vs Zydus Lifesciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Balaxi Pharmaceuticals Ltd is ₹ 22.85 as of 12 Jun 15:30 . The P/E Ratio of Balaxi Pharmaceuticals Ltd changed from 13.8 on March 2021 to 14.1 on March 2025 . This represents a CAGR of 0.43% over 5 yearsThe P/E Ratio of Zydus Lifesciences Ltd changed from 21.1 on March 2021 to 19.7 on March 2025 . This represents a CAGR of -1.36% over 5 years The Market Cap of Balaxi Pharmaceuticals Ltd changed from ₹ 524.5 crore on March 2021 to ₹ 352.89 crore on March 2025 . This represents a CAGR of -7.62% over 5 yearsThe Market Cap of Zydus Lifesciences Ltd changed from ₹ 45131 crore on March 2021 to ₹ 89122 crore on March 2025 . This represents a CAGR of 14.58% over 5 years The revenue of Balaxi Pharmaceuticals Ltd for the Mar '26 is ₹ 73.63 crore as compare to the Dec '25 revenue of ₹ 72.64 crore. This represent the growth of 1.36% The revenue of Zydus Lifesciences Ltd for the Mar '26 is ₹ 7721 crore as compare to the Dec '25 revenue of ₹ 6975 crore. This represent the growth of 10.68% The ebitda of Balaxi Pharmaceuticals Ltd for the Mar '26 is ₹ 3.04 crore as compare to the Dec '25 ebitda of ₹ 3.19 crore. This represent the decline of -4.7% The ebitda of Zydus Lifesciences Ltd for the Mar '26 is ₹ 2291 crore as compare to the Dec '25 ebitda of ₹ 1842 crore. This represent the growth of 24.32% The net profit of Balaxi Pharmaceuticals Ltd changed from ₹ 6.48 crore to ₹ 0.61 crore over 8 quarters. This represents a CAGR of -69.32% The net profit of Zydus Lifesciences Ltd changed from ₹ 1463 crore to ₹ 1341 crore over 8 quarters. This represents a CAGR of -4.27% The Dividend Payout of Balaxi Pharmaceuticals Ltd changed from 3.41 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Zydus Lifesciences Ltd changed from 24.28 % on March 2021 to 19.16 % on March 2025 . This represents a CAGR of -4.63% over 5 years .

About Balaxi Pharmaceuticals Ltd

Balaxi Pharmaceuticals Limited was initially incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942.
The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017 and further changed to Balaxi Pharmaceuticals Limited in 2021.
Initially, the Company was incorporated with the object of running rubber and tea plantations and owns several plantations across South India. In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading.
The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.

About Zydus Lifesciences Ltd

Zydus Lifesciences Limited, initially known as Cadila Healthcare Limited was incorporated in May, 1995, which changed to Zydus Lifesciences Limited on February 24, 2022.
The Company is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products.
The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. The Company's operation includes pharmaceuticals, which includes human formulations, veterinary formulations and bulk durgs, diagnostics, herbal products, skin care products and OTC products.

FAQs for the comparison of Balaxi Pharmaceuticals Ltd and Zydus Lifesciences Ltd

Which company has a larger market capitalization, Balaxi Pharmaceuticals Ltd or Zydus Lifesciences Ltd?

Market cap of Balaxi Pharmaceuticals Ltd is 126 Cr while Market cap of Zydus Lifesciences Ltd is 111,123 Cr

What are the key factors driving the stock performance of Balaxi Pharmaceuticals Ltd and Zydus Lifesciences Ltd?

The stock performance of Balaxi Pharmaceuticals Ltd and Zydus Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Balaxi Pharmaceuticals Ltd and Zydus Lifesciences Ltd?

As of June 15, 2026, the Balaxi Pharmaceuticals Ltd stock price is INR ₹22.85. On the other hand, Zydus Lifesciences Ltd stock price is INR ₹1104.35.

How do dividend payouts of Balaxi Pharmaceuticals Ltd and Zydus Lifesciences Ltd compare?

To compare the dividend payouts of Balaxi Pharmaceuticals Ltd and Zydus Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.